Caris Life Sciences (NASDAQ:CAI) executives said the company is expanding its commercial reach, product pipeline and ...
Introducing a new RNA-seq platform for intracellular multimodal profiling that could transform cancer research and ...
Real-time nanopore transcriptomics enables early detection of expression changes and sample quality, offering a rapid, cost-effective strategy for experimental quality control and transcriptomic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results